Nasopharyngeal carcinoma (NPC) is a malignant tumor arising from the mucosal epithelium of the nasopharynx, accounting for 2-3% of head and neck cancers. It has a strong association with Epstein-Barr virus (EBV) and shows striking geographic distribution — endemic in Southeast Asia (especially Southern China) with an incidence of 25-50 per 100,000. WHO classification defines three subtypes: Type I (keratinizing SCC, 5%), Type II (non-keratinizing differentiated, 15%), and Type III (non-keratinizing undifferentiated, 80% — most common, best prognosis, most radiosensitive). The tumor typically originates from the fossa of Rosenmuller (pharyngeal recess) and can spread submucosally. MRI is superior to CT for primary tumor evaluation — particularly critical for detecting perineural spread, skull base invasion, cavernous sinus involvement, and retrobulbar extension. CT has a complementary role in evaluating bone erosion and calcification.
Age Range
30-60
Peak Age
50
Gender
Male predominant
Prevalence
Uncommon
NPC develops through EBV-mediated transformation of nasopharyngeal epithelium. EBV latent membrane protein-1 (LMP-1) increases cell proliferation and inhibits apoptosis. The tumor typically originates from the fossa of Rosenmuller because this region contains a transition zone between lymphoid tissue and surface epithelium that is susceptible to carcinogenesis. Due to submucosal growth pattern, the superficial mucosa may appear normal — this complicates endoscopic diagnosis and increases the importance of MRI. The tumor's rich lymphoid stroma (especially in WHO Type III) causes homogeneous or mildly heterogeneous enhancement — diffuse vascularity predominates rather than irregular neovascularization. High cellularity causes prominent diffusion restriction on DWI. Obliteration of the parapharyngeal fat plane is the earliest radiologic sign of deep space spread, best evaluated on MRI. Skull base erosion results from direct bone invasion by the tumor and can lead to intracranial extension via foramen ovale/lacerum. Perineural spread is particularly tracked along the trigeminal nerve (V2/V3) — seen as nerve thickening and abnormal enhancement on MRI.
Asymmetric nasopharyngeal mass originating from the fossa of Rosenmuller with obliteration of the parapharyngeal fat plane is the signature finding of NPC. This combination distinguishes NPC from other nasopharyngeal pathologies (adenoid hypertrophy, Thornwaldt cyst, lymphoma) with high specificity. Best evaluated on contrast-enhanced fat-suppressed T1 sequences.
Asymmetric soft tissue mass arising from the nasopharyngeal lateral wall, showing isointense signal to muscle. The fossa of Rosenmuller (pharyngeal recess) is the most common origin point. Shows isointense or mildly hypointense signal to muscle on T1. Due to submucosal growth pattern, superficial mucosa may appear normal — making MRI superior to endoscopy for primary diagnosis.
Report Sentence
An asymmetric soft tissue mass measuring ___ mm is identified at the right/left lateral nasopharyngeal wall at the level of the fossa of Rosenmuller, showing isointense signal to muscle on T1.
Obliteration of the parapharyngeal fat plane by tumor infiltration — the earliest and most reliable MRI finding of deep NPC infiltration. Normal parapharyngeal fat appears as bright hyperintense area on T1; tumor infiltration causes loss of this fat signal. Best evaluated on contrast-enhanced fat-suppressed T1 sequences — when fat signal is suppressed, enhancing tumor tissue becomes conspicuous in the parapharyngeal space.
Report Sentence
The right/left parapharyngeal fat plane is obliterated by the mass, consistent with deep space invasion; pathologic enhancement is seen in the parapharyngeal space on contrast-enhanced fat-suppressed T1 sequences.
Skull base bone erosion: Foramen ovale, foramen lacerum, petrous apex, clivus, and pterygoid plates are the most commonly affected structures. CT is superior to MRI for evaluating bone erosion. Thin-section CT (≤1 mm) best evaluates cortical bone continuity. Bone erosion determines T4 stage (AJCC/UICC) and carries risk of intracranial extension.
Report Sentence
Cortical bone erosion is identified at the skull base at the level of foramen ovale/foramen lacerum/clivus, consistent with T4 stage nasopharyngeal carcinoma; intracranial extension should be evaluated with MRI.
Marked diffusion restriction: NPC shows bright signal on DWI and low signal on ADC map due to high cellularity. ADC value is typically <0.8 × 10⁻³ mm²/s. In treatment response monitoring, ADC increases (cellularity decreases) — used for quantitative assessment of treatment response. Most sensitive MRI sequence for recurrence detection.
Report Sentence
The nasopharyngeal mass demonstrates marked diffusion restriction on DWI (ADC: ___ × 10⁻³ mm²/s), consistent with a malignant lesion with high cellularity.
Perineural spread: Tumor spread along trigeminal nerve branches (V2-foramen rotundum, V3-foramen ovale) particularly in NPC. Abnormal enhancement and nerve thickening along nerve canals on contrast-enhanced MRI. Beyond mechanical classification (impact on T stage of foraminal area). Can be a precursor to cavernous sinus invasion.
Report Sentence
Pathologic thickening and enhancement along the right/left trigeminal nerve V2/V3 branch is identified, consistent with perineural tumor spread.
Retropharyngeal LAP: Enlargement of lateral retropharyngeal (Rouviere) lymph nodes, the first and most common metastatic site of NPC. Short axis >5 mm or central necrosis is considered pathologic. Bilateral retropharyngeal LAP is highly characteristic of NPC. Appears as enhancing retropharyngeal nodes with or without central necrosis on CT.
Report Sentence
Pathologically enlarged enhancing lymph nodes (short axis ___ mm) are identified in bilateral retropharyngeal spaces, consistent with nodal metastasis from nasopharyngeal carcinoma.
High FDG uptake on PET-CT: NPC shows high metabolic activity (SUVmax typically 8-20). Enables single-session evaluation of primary tumor, retropharyngeal/cervical LAP, and distant metastases. Has a critical role in treatment response assessment. WHO Type III shows the highest FDG uptake.
Report Sentence
The nasopharyngeal mass demonstrates intense metabolic activity on FDG-PET (SUVmax: ___); simultaneous evaluation for retropharyngeal/cervical LAP and distant metastases has been performed.
Criteria
5% of all NPC. Keratinization and intercellular bridges present. Weak EBV association. Smoking/alcohol are risk factors. Relatively more common in Western countries.
Distinct Features
Poorer prognosis compared to other types, lower response to radiotherapy, frequently presents at locally advanced stage. CT/MRI findings indistinguishable from other types.
Criteria
15% of all NPC. Distinct cell borders, plexiform growth pattern. Strong EBV association. Moderate radiosensitivity.
Distinct Features
Better prognosis than Type I, worse than Type III. Treatment with radiotherapy + chemotherapy. CT/MRI findings indistinguishable from other types.
Criteria
80% of all NPC — most common subtype. No distinct cell borders, syncytial growth, dense lymphoid infiltrate. Strongest EBV association. Highest radiosensitivity.
Distinct Features
Best prognosis — 5-year survival >90% in early stage. Most prominent diffusion restriction on DWI due to dense lymphoid stroma. Highest FDG uptake on PET-CT. High response rate with radiotherapy + cisplatin chemotherapy.
Distinguishing Feature
Adenoid hypertrophy is symmetric and homogeneous, no bone erosion, pediatric age group; NPC is asymmetric, infiltrative, with bone erosion, adult
Distinguishing Feature
Thornwaldt cyst is midline cystic lesion, T1 hyperintense, no enhancement; NPC is lateral wall solid mass, enhancing, infiltrative
Distinguishing Feature
Lymphoma shows minimal/no bone erosion, homogeneous mass; NPC shows prominent bone erosion, perineural spread present
Distinguishing Feature
Metastasis has known primary malignancy, may be bilateral, EBV negative; NPC is EBV positive, fossa of Rosenmuller origin is typical
Urgency
urgentManagement
medicalBiopsy
NeededFollow-up
specialist-referralNPC shows high radiosensitivity — early stage (T1-T2, N0-1) treated with IMRT alone, advanced stage with concurrent chemoradiotherapy (cisplatin-based) + adjuvant chemotherapy. EBV DNA titer is used as biomarker for diagnosis, treatment response, and recurrence monitoring. IMRT (intensity-modulated radiotherapy) spares parotid glands reducing xerostomia risk. Five-year survival: Stage I 90%, Stage II 80%, Stage III 70%, Stage IVA 60%.
Nasopharyngeal carcinoma is highly radiosensitive. Radiotherapy alone is the standard for early stage (T1-T2), concurrent chemoradiotherapy (cisplatin-based) for advanced stage. EBV DNA titer is used for treatment response monitoring and recurrence surveillance. Five-year survival is approximately 90% in stage I and 60% in stage IVA.